Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Oral brivudin versus intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial — Peter Wutzler (1995) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Oral brivudin versus intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial
Shared by
De Clercq Erik
KU Leuven
Oral brivudin versus intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial
Article
1995
en
Authors
+1 more
PW
Peter Wutzler
De Clercq Erik
KU Leuven
KW
K Wutke
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1995
Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: A randomized double‐blind trial
Peter Wutzler
,
De Clercq Erik
,
K Wutke
,
Inge Färber
Article
2017
Randomized double blind trial of amitriptyline versus placebo in treatment of chronic laryngopharyngeal neuropathy
Minyoung Jang
,
Samuel J. Rubin
,
Dan Joseph Stein
,
J. Pieter Noordzij
Article
2004
Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster
De Clercq Erik
Chapter in a book
1985
Oral Bromovinyldeoxyuridine Treatment of Herpes Zoster Ophthalmicus
P. C. Maudgal
,
M Dieltiëns
,
L Missotten
,
De Clercq Erik
Article
2017
Randomized Double Blind Trial of Amitriptyline versus Placebo in Treatment of Chronic Laryngopharyngeal Neuropathy- Preliminary Results
Minyoung Jang
,
Samuel J. Rubin
,
Dan Joseph Stein
,
J. Pieter Noordzij
Discussion(0)
No comments yet. Be the first to comment.